Table 3.
Survival Duration Based on Variables Associated with HCC
| Variable | Survival Duration | ||
|---|---|---|---|
| Median (Months) | Range (Months) | ||
| Insurance | Uninsured | 8.35 | 3.28–18.61 |
| Insured | 32.02 | 8.71–89.62 | |
| Initial MELD | ≤10 | 26.63 | 12.10–106.91 |
| >10 | 14.3 | 3.75–59.28 | |
| Final MELD | ≤13 | 62.43 | 19.36–106.91 |
| >13 | 12.1 | 3.85–31.04 | |
| Milan criteria | No | 12.23 | 3.75–37.87 |
| Yes | 36 | 15.65–89.62 | |
| Treatment for HCC | No | 9.8 | 3.48–37.87 |
| Yes | 24.95 | 9.53–64.87 | |
| Transplant Referral | No | 12.66 | 3.75–62.43 |
| Yes | 26.63 | 17.46–64.87 | |
| Hospice care | No | 45.04 | 3.85–45.04 |
| Yes | 9.8 | 12.23–62.43 | |
| Surveillance | No | 14.3 | 3.85–45.04 |
| Yes | 26.63 | 12.23–62.43 | |
Abbreviations: HCC, hepatocellular carcinoma; MELD, Model for End Stage Liver Disease.